Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NCLH vs GSK✓SelectedUSD · GSKNCLH vs GSK performance historyLatest closeAs of+2.16%11/18
Stock and ETF performance explorer

NCLH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-27.4%
GSK return
+118.6%
Excess return
-146.0%
Maximum drawdown
-87.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+2.2%-1.3%+3.5%+2.7%
7D-4.4%-3.1%-1.3%-3.1%
30D+18.0%-0.9%+18.9%+18.4%
3M+2.2%-4.2%+6.3%+3.7%
6M+17.9%-1.6%+19.5%+18.0%
YTD-19.4%+2.6%-22.0%-20.6%
1Y+0.8%+6.2%-5.4%-2.1%
3Y+20.5%+55.0%-34.5%-7.4%
5Y-23.7%+42.8%-66.5%-39.8%
10Y-54.7%+102.1%-156.8%-69.2%
All-27.4%+118.6%-146.0%-50.4%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling